# A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD

> **NCT01761292** · PHASE1,PHASE2 · COMPLETED · sponsor: **Italfarmaco** · enrollment: 20 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy (DMD)

## Interventions

- **DRUG:** Givinostat

## Key facts

- **NCT ID:** NCT01761292
- **Lead sponsor:** Italfarmaco
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-12
- **Final completion:** 2017-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761292, "A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01761292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*